Jennifer G Goldman

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. pmc Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Parkinsonism Relat Disord 19:806-11. 2013
  2. pmc Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Mov Disord 27:1129-36. 2012
  3. ncbi request reprint Treatment of dystonia
    Jennifer G Goldman
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, 1725 W Harrison Street, Suite 755, Chicago, IL 60612, USA
    Clin Neuropharmacol 26:102-8. 2003
  4. ncbi request reprint Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system
    Jennifer G Goldman
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
    Arch Neurol 61:1280-4. 2004
  5. doi request reprint Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 23:2248-50. 2008
  6. pmc An update expert opinion on management and research strategies in Parkinson's disease psychosis
    Jennifer G Goldman
    Rush University Medical Center, Department of Neurological Sciences, 1725 W Harrison Street, Chicago, IL 60612, USA
    Expert Opin Pharmacother 12:2009-24. 2011
  7. pmc Mild cognitive impairment in Parkinson's disease
    J G Goldman
    Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University, Chicago, IL 60612, USA
    Minerva Med 102:441-59. 2011
  8. doi request reprint Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia
    Brandon Barton
    Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:248-53. 2012
  9. pmc Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:727-34. 2012
  10. doi request reprint Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations
    Jennifer G Goldman
    1 Rush University Medical Center, Department of Neurological Sciences, Chicago, IL, USA
    Brain 137:849-59. 2014

Detail Information

Publications12

  1. pmc Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Parkinsonism Relat Disord 19:806-11. 2013
    ..Thus, we examined the relationships among excessive daytime sleepiness, nighttime sleep quality and cognitive impairment in PD, including severity and specific cognitive deficits...
  2. pmc Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Mov Disord 27:1129-36. 2012
    ..Furthermore, increased burden of cognitive dysfunction, rather than type of cognitive deficit, may be associated with greater motor impairment in PD-MCI...
  3. ncbi request reprint Treatment of dystonia
    Jennifer G Goldman
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, 1725 W Harrison Street, Suite 755, Chicago, IL 60612, USA
    Clin Neuropharmacol 26:102-8. 2003
    ..Studies in functional outcome and quality of life further support the importance of discovering safe and effective means to treat dystonia. An algorithmic approach may be useful to guide the physician along the various treatment choices...
  4. ncbi request reprint Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system
    Jennifer G Goldman
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
    Arch Neurol 61:1280-4. 2004
    ..Because CCK gene polymorphisms vary across ethnic groups, the presence of similar associations in white PD subjects merits investigation...
  5. doi request reprint Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 23:2248-50. 2008
    ..Our results suggest that dopaminergic medications have limited benefit in DLB because of the low likelihood of motor improvement and the risk of psychosis exacerbation...
  6. pmc An update expert opinion on management and research strategies in Parkinson's disease psychosis
    Jennifer G Goldman
    Rush University Medical Center, Department of Neurological Sciences, 1725 W Harrison Street, Chicago, IL 60612, USA
    Expert Opin Pharmacother 12:2009-24. 2011
    ..Safe, effective treatments that improve psychosis without exacerbating parkinsonism are urgently needed...
  7. pmc Mild cognitive impairment in Parkinson's disease
    J G Goldman
    Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University, Chicago, IL 60612, USA
    Minerva Med 102:441-59. 2011
    ..Future studies using uniform PD-MCI diagnostic criteria and incorporating biomarkers and longitudinal follow-up of PD-MCI cohorts are needed to understand PD-MCI as a transitional state between normal cognition and dementia...
  8. doi request reprint Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia
    Brandon Barton
    Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:248-53. 2012
    ..Revision of the checklist by altering or eliminating the 2 problematic checklist items may improve sensitivity...
  9. pmc Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:727-34. 2012
    ..Thus, ERC atrophy on MRI may be a potential biomarker for dementia in PD, particularly in the setting of memory impairment...
  10. doi request reprint Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations
    Jennifer G Goldman
    1 Rush University Medical Center, Department of Neurological Sciences, Chicago, IL, USA
    Brain 137:849-59. 2014
    ....
  11. doi request reprint Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 28:1972-9. 2013
    ..The predominance of multiple domain impairment in PD-MCI with the Level II criteria suggests not only influences of testing abnormality requirements, but also the widespread nature of cognitive deficits within PD-MCI...
  12. doi request reprint I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 29:115-7. 2014
    ..The objective of this work was to investigate neuroanatomical substrates active during visual hallucinations in a patient with Parkinson's disease (PD)...